The First Affilated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
NCT Number: NCT04203420
The guideline requires clinical works to screen for primary aldosteronism(PA) in young adults with family history of stroke at early onset. But the prevalence of PA in young adults with stroke onset before 45 years old had never been investigated. The study aimed to discover the prevalence as well as the clinical characteristics between patients with PA and those without PA during stroke attack. In order to fulfill this objective, investigators intended to conduct a cross-sectional study by taking screening and confirmatory tests among young adults who once admitted due to early onset of acute stroke.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Observational
Chongqing, Chongqing Municipality, 400016, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
death, serious sequela with motor, comprehensive or linguistic dysfunction, patients unwilling to join in, etiology of trauma, infective or tumor disease, patients with impaired cardiac, renal or liver function during admission-
screening test is a blood test of the ratio of plasma aldosterone concentration(PAC) and direct renin concentration(DRC), confirmatory test is Captopril Challenge test
Time frame: through study completion, an average of 2 years
to find out the proportion of PA patients in young adults with early onset of acute stroke
Chongqing Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07700888
Adrenal Gland Diseases, Adrenocortical Hyperfunction
Beijing, 李泽文, China
View Trial DetailsNCT02756754
ACTH Syndrome, Ectopic, Adrenal Adenoma
Bordeaux, France
View Trial DetailsNCT04605549
Adrenal Gland Diseases, Adrenocortical Hyperfunction
Greenbrae, California, United States
View Trial DetailsNCT05757076
Adrenal Gland Diseases, Adrenocortical Hyperfunction
Cleveland, Ohio, United States
View Trial Details